At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
FreeStyle Navigator II Continuous Glucose Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
FreeStyle Navigator II Continuous Glucose Monitor Home Use Evaluation (FSNv2)
In Brief
An observational study evaluating FreeStyle Navigator II Continuous Glucose Monitoring System for Diabetes. Completed, enrolled 31 participants across 2 sites.
Detailed Summary
This research study will test a new investigational continuous glucose monitoring system (System). The purpose of this study is to find out about the performance of the System in a home use environment over a 15 day period, in people with diabetes.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
First PostedOct 2011
Primary CompletionDec 2011
Study CompletionJan 2012
TodayJul 2026
First PostedOct 19, 2011
Enrollment StartOct 1, 2011
Primary CompletionDec 1, 2011
Study CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.7 years ago
Interventions
FreeStyle Navigator II Continuous Glucose Monitoring Systemdevice
This is not an interventional study. Subjects must maintain their own diabetes treatment regimen throughout the study duration